Quarterly report [Sections 13 or 15(d)]

Stockholders??? Equity (Details)

v3.26.1
Stockholders’ Equity (Details) - USD ($)
 3 Months Ended 12 Months Ended
Jan. 28, 2026
Nov. 28, 2025
Jun. 20, 2025
Nov. 26, 2024
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Sep. 03, 2025
May 06, 2025
Dec. 31, 2024
Stockholders’ Equity [Line Items]                    
Number of aggregate authorized shares         505,000,000          
Common stock, shares authorized         500,000,000   500,000,000      
Common stock, par value         $ 0.0001   $ 0.0001      
Preferred stock, shares authorized         5,000,000   5,000,000      
Preferred stock, par value         $ 0.0001   $ 0.0001      
Common stock shares issued         24,939,948   23,091,062      
Common stock shares outstanding         24,939,948   23,091,062      
Common stock, voting rights         one          
Stock option outstanding         1,685,843   1,685,843      
Price per share         $ 0.75          
Warrants term         5 years          
Percentage of commission       3.00%            
Common stock         $ 2,494   $ 2,309      
Beneficial ownership limitation effective days         61 days          
Aggregate net proceeds         $ 4,200,000          
Net proceeds public offering         54,900,000          
Fair value of placement agent warrants           3,842,857      
Net proceeds         $ 1,652,745        
Reclassification to equity of the placement agent warrants liability         2,294,631          
Shares exercised value         750 $ 871        
Cancellation of shares, value         $ 1,101          
Shares issued and paid but unexercised                
Pre-Funded Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants purchase   65,153,335                
Warrants exercise price         $ 0.001          
Placement Agent Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Placement agent warrant issuance costs         $ 3,426,238          
May 2025 Pre-Funded Warrant [Member]                    
Stockholders’ Equity [Line Items]                    
Price per share         $ 1.399          
Issuance of common stock from the exercise of pre-funded warrants         477,144          
Series C Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants exercise price         $ 1.4          
Series D warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants exercise price         $ 1.4          
Warrants term         18 months          
Proceeds from warrant exercises         $ 6,300,000          
May 2025 Placement Agent Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants purchase         250,000          
Warrants exercise price         $ 1.75          
Warrants term         5 years          
December 2025 Pre-Funded Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants purchase   65,153,335                
Warrants exercise price         $ 0.001          
Price per share         $ 0.749          
Issuance of common stock         1,850,000          
Beneficial ownership limitation effective days         61 days          
Shares issued and paid but unexercised         63,303,335          
December 2025 Placement Agent Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Loss on warrant liability             $ 416,619      
Reclassification to equity of the placement agent warrants liability $ 2,294,631                  
Risk free interest rate 3.83%                  
Volatility rate 115.83%                  
Stock price $ 0.85                  
Private Investment in Public Equity (PIPE) Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Own beneficially percentage         4.99%          
Private Investment in Public Equity (PIPE) Warrants [Member] | Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Own beneficially percentage         9.99%          
Ownership Limitation [Member] | Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Own beneficially percentage         9.99%          
December 2025 Public Offering [Member]                    
Stockholders’ Equity [Line Items]                    
Own beneficially percentage         4.99%          
December 2025 Public Offering [Member] | Pre-Funded Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Own beneficially percentage         9.99%          
2021 Stock Incentive Plan [Member]                    
Stockholders’ Equity [Line Items]                    
Stock option outstanding         61,250          
2023 Plan [Member]                    
Stockholders’ Equity [Line Items]                    
Common stock shares issued         1,624,593          
Common stock shares outstanding         1,624,593          
Number of shares available for issuance         12,375,407          
Unused shares         28,389          
Common stock outstanding shares percentage         3.00%          
Common Stock [Member]                    
Stockholders’ Equity [Line Items]                    
Common stock, shares authorized         500,000,000          
Common stock shares issued         1,848,886          
Warrants purchase                 1  
Sell aggregate share   14,846,665                
Issuance of common stock         750,000 871,000        
Reclassification to equity of the placement agent warrants liability                  
Shares exercised value         $ 75 $ 87        
Cancellation of shares         1,114          
Common Stock [Member] | May 2025 Pre-Funded Warrant [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants purchase                 3,571,428  
Common Stock [Member] | Series C Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants purchase         1          
Common Stock [Member] | Series D warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants purchase         914,286          
Gross proceeds         $ 1,300,000          
Common Stock [Member] | December 2025 Placement Agent Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants purchase         4,000,000          
Warrants exercise price         $ 0.9375          
Common Stock [Member] | December 2025 Public Offering [Member]                    
Stockholders’ Equity [Line Items]                    
Own beneficially percentage         9.99%          
Common Stock [Member] | 2023 Plan [Member]                    
Stockholders’ Equity [Line Items]                    
Number of shares authorized         14,000,000          
ATM Agreement [Member] | Common Stock [Member]                    
Stockholders’ Equity [Line Items]                    
Price per share           $ 3.88        
Common stock                   $ 2,076,000
Gross proceeds           $ 1,705,528        
Sell aggregate share         440,000        
Aggregate additional shares sold     $ 2,151,000              
Net proceeds           $ 1,652,745        
Securities Purchase Agreements [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants purchase                 3,571,428  
Securities Purchase Agreements [Member] | Pre-Funded Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants purchase                 477,144  
Securities Purchase Agreements [Member] | Series C Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants purchase                 3,571,428  
Securities Purchase Agreements [Member] | Series D warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants purchase         3,571,428          
Securities Purchase Agreements [Member] | Common Stock [Member]                    
Stockholders’ Equity [Line Items]                    
Issued common stock warrants purchase                 3,094,284  
Securities Purchase Agreements [Member] | Common Stock [Member] | Pre-Funded Warrants [Member]                    
Stockholders’ Equity [Line Items]                    
Warrants purchase                 477,144  
Restricted Stock Units [Member] | 2023 Plan [Member]                    
Stockholders’ Equity [Line Items]                    
Number of shares available for issuance         125,000          
Minimum [Member] | Common Stock [Member]                    
Stockholders’ Equity [Line Items]                    
Number of shares authorized 100,000,000                  
Minimum [Member] | Common Stock [Member] | 2023 Plan [Member]                    
Stockholders’ Equity [Line Items]                    
Number of shares authorized 11,985,779             1,750,000    
Minimum [Member] | ATM Agreement [Member]                    
Stockholders’ Equity [Line Items]                    
Common stock shares issued     2,076,000              
Maximum [Member] | Common Stock [Member]                    
Stockholders’ Equity [Line Items]                    
Number of shares authorized 500,000,000                  
Maximum [Member] | Common Stock [Member] | 2023 Plan [Member]                    
Stockholders’ Equity [Line Items]                    
Number of shares authorized 14,000,000             2,014,221    
Maximum [Member] | ATM Agreement [Member] | Common Stock [Member]                    
Stockholders’ Equity [Line Items]                    
Common stock shares issued     4,227,000              
IPO [Member]                    
Stockholders’ Equity [Line Items]                    
Price per share         $ 1.4